LifeStance Health Group Inc Dossier
|
SectorHealth Care IndustryMedical Care Facilities Beta (adjusted)1.13 Intrinsic Value Insufficient data for a value estimateNot enough reliable inputs to publish a fair value for this company yet. Market Price $11.91Price as of 1 Oct 2026 Data confidenceNot applicable Market Cap $4.5B Enterprise Value $4.6B Shares Outstanding 397.3M diluted Moat Rating None Next Earnings Date5 Nov 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary LifeStance Health Group, Inc. (LFST) is successfully executing its operational turnaround, transitioning from a period of rapid, unintegrated center expansion to a highly disciplined, productivity-focused model. The company's Q1 2026 results demonstrate powerful operating leverage, with revenue growing 21% year-over-year to $403.5 million and Adjusted EBITDA expanding 48% to $51.1 million. By leveraging its massive scale as one of the nation's largest outpatient mental health providers, LifeStance is uniquely positioned to capture secular tailwinds in mental healthcare demand while expanding margins through improved clinician utilization, digital platform optimization, and favorable commercial payer rate negotiations. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$12.00 Mean target$13.60 High · most bullish analyst$16.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $12.0015% Clinician attrition rises due to intense competition from digital-only telehealth platforms and regional health systems. Payer consolidation or aggressive cost-containment strategies by major insurers (such as UnitedHealthcare or Elevance Health) compress average revenue per visit, stalling margin expansion and limiting free cash flow. Base CaseCentral scenario $13.6060% Matches the consensus meanLifeStance continues to grow its clinician base at a steady pace (10-12% annually) and maintains stable clinician productivity. Full-year 2026 revenue meets raised guidance of $1.64 billion to $1.68 billion, and Adjusted EBITDA lands within the $200 million to $220 million range. Free cash flow generation remains positive, supporting ongoing share repurchases and selective practice acquisitions. Bull CaseUpside scenario $16.0025% Accelerated clinician hiring combined with higher-than-expected productivity gains drives market share expansion. Commercial payers agree to higher reimbursement rates due to LifeStance's proven clinical outcomes study (showing ~75% of patients with clinically significant improvement). Operating leverage expands Adjusted EBITDA margins toward the mid-teens ahead of the 2028 target. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |